liver disease

Aug 24, 2021

FDA Grants De Novo Authorization for Siemens Healthineers' Enhanced Liver Fibrosis Blood Test

Jun 9, 2021

Owlstone Medical Entering Digestive Health Dx Space With Launch of Breath-Based Testing Service
Premium

May 19, 2021

Digital Pathology Firm PathAI Raises $165M in Series C Financing

May 13, 2021

Genfit Moves Into Dx Business With Labcorp's Launch of NASH Assay
Premium

Apr 14, 2021

GlycoPath to Develop MALDI Mass Spec Test for Liver Fibrosis
Premium

Dec 15, 2020

Siemens Healthineers, Gilead Sciences, Renown Institute Collaborate on Liver Fibrosis Testing

Dec 15, 2020

HistoIndex Joins Consortium Developing Liver Disease Diagnostic Tool

Sep 30, 2020

Owlstone Medical, Addenbrooke's Hospital See Promise in Breath Dx Test for Staging Liver Disease

Sep 28, 2020

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

Aug 24, 2020

Fibronostics Raises $8M in Series A Round

Jul 22, 2020

Glympse Bio Platform Enters Trials for Liver Disease Diagnosis, Treatment Monitoring

Apr 29, 2020

DiscernDx Acquires Luminist Labs

Feb 6, 2020

ProSciento, Nordic Bio Partner on Translational Biomarkers for NASH

Oct 15, 2019

Cleveland Clinic, Owlstone Medical Partner, Establish Early Disease Detection Center

Aug 20, 2019

Group K Diagnostics, Health Network Laboratories Commence Clinical Trial for Liver Function Test

Jun 11, 2019

European Team Developing Blood Test for Pediatric Non-Alcoholic Fatty Liver Disease
Premium

Apr 9, 2019

Gut Microbiome Signature to Be Developed as Nonalcoholic Fatty Liver Disease Diagnostic
Premium

Apr 3, 2019

Group K Diagnostics Readies Liver Function Microfluidic for FDA Submission In Bid to Enter POC Testing
Premium

Mar 21, 2019

Ortho Clinical Dx Collaborating With Chinese IVD Firm

Jan 3, 2019

LabCorp's Covance Licenses Genfit's NASH Test